Hiroyuki Yamamoto

ヤマモトヒロユキ | Hiroyuki Yamamoto

Affiliation and department：

Research field (3)： Pathobiochemistry , Tumor biology , Tumor diagnostics and therapeutics

Research keywords (3)：甲状腺ホルモン受容体 , 食道がん , 皮膚がん

Research theme for competitive and other funds (5)：

Papers (13)：

Ali Calderon-Aparicio, Hiroyuki Yamamoto, Humberto De Vitto, Tianshun Zhang, Qiushi Wang, Ann M Bode, Zigang Dong. RCC2 Promotes Esophageal Cancer Growth by Regulating Activity and Expression of the Sox2 Transcription Factor. Molecular cancer research : MCR. 2020. 18. 11. 1660-1674
Wang Q, Gao G, Zhang T, Yao K, Chen H, Park MH, Yamamoto H, Wang K, Ma W, Malakhova M, et al. TRAF1 Is Critical for Regulating the BRAF/MEK/ERK Pathway in Non-Small Cell Lung Carcinogenesis. Cancer research. 2018. 78. 14. 3982-3994
Yao K, Lee SY, Peng C, Lim DY, Yamamoto H, Ryu J, Lim TG, Chen H, Jin G, Zhao Z, et al. RSK2 is required for TRAF6 phosphorylation-mediated colon inflammation. Oncogene. 2018. 37. 26. 3501-3513
Naomi Oi, Hiroyuki Yamamoto, Alyssa Langfald, Ruihua Bai, Mee-Hyun Lee, Ann M. Bode, Zigang Dong. LTA4H regulates cell cycle and skin carcinogenesis. CARCINOGENESIS. 2017. 38. 7. 728-737
Hiroyuki Yamamoto, Joohyun Ryu, Eli Min, Naomi Oi, Ruihua Bai, Tatyana A. Zykova, Dong Hoon Yu, Kenji Moriyama, Ann M. Bode, Zigang Dong. TRAF1 Is Critical for DMBA/Solar UVR-Induced Skin Carcinogenesis. JOURNAL OF INVESTIGATIVE DERMATOLOGY. 2017. 137. 6. 1322-1332

ｍore...

MISC (23)：

ｍore...

Professional career (1)：

Work history (5)：

2021/04 - 現在 Junshin Gakuen University
2018/01 - 2021/03 Junshin Gakuen University
2011/03 - 2017/11 The Hormel institute, University of Minnesota Researcher 5
2007/10 - 2011/03 Mukogawa Women's University School of Pharmacy and Pharmaceutical Sciences, Department of Pharmacy
2004/04 - 2006/03 神戸大学医学研究科日本学術振興会特別研究員(DC1)

Association Membership(s) (2)：

日本癌学会 , AACR

※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page